CT-P13: Clinical Trials

5 trials of CT-P13, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 recruiting. 5 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1
Phase 12Active not recruiting 1, Unknown 1
Phase 31Completed 1

Follow CT-P13: new trials by email Literature Review of CT-P13 trials Research Report on CT-P13

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Cytokine Release Syndrome, Recurrent Multiple Myeloma
Phase 2RecruitingNaresh Bumma352026-07-172026-10-06
Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial
Infliximab-dyyb Biosimilar (Remsima) - Moderate to Severe Chronic Plaque Psoriasis
Phase 1 / Phase 2UnknownServices Institute of Medical Sciences, Pakistan1042023-11-062024-09-19
MIS-C Comparative Effectiveness Study
Infliximab, Anakinra, Methylprednisolone - Multisystem Inflammatory Syndrome-Children
Phase 2 / Phase 3CompletedUniversity of California, San Diego732020-12-222025-11-04
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center472020-07-092026-07-15
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
remicade (anti tumor necrosis factor inhibitor) - Takayasu's Arteritis
Phase 2UnknownSeoul National University Hospital112015-03-012017-05-15

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Colitis (1)  ·  Cytokine Release Syndrome (1)  ·  Melanoma (1)  ·  Multiple Myeloma (1)  ·  Takayasu Arteritis (1)  ·  Urogenital Neoplasms (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Naresh Bumma (1)  ·  Seoul National University Hospital (1)  ·  Services Institute of Medical Sciences, Pakistan (1)  ·  University of California, San Diego (1)

Countries

United States (3)  ·  Pakistan (1)  ·  South Korea (1)

Top investigators

Adriana Tremoulet, MD, MAS (1)  ·  Dr Hira Tariq, MBBS, FCPS Derma (1)  ·  Naresh Bumma, MD (1)  ·  Yeong Wook Song, MD,PhD (1)  ·  Yinghong Wang (1)

Results publications

PMID 30229280, PMID 36694613, PMID 42617793